You are viewing an older, archived article. There may be more up to date articles on this subject, try a new search

INR Testing

Key Messages INR PDF
Introduction
Initiation of warfarin therapy
Monitoring INR
Other issues for INR management
Appendices
References

References

BC Health Services, British Columba Medical Association. Initiation and Maintenance of Warfarin Therapy, 2004. http://www.healthservices.gov.bc.ca/msp/protoguides/gps/warfarin_therapy.pdf (accessed 22 September 2006).

Blann AD, Fitzmaurice DA, Lip GYH. Anticoagulation in hospitals and general practice. BMJ 2003;326:153-6.

Campbell P et al. Managing warfarin therapy in the community. Aust Prescr 2001;24:86-9.

Didham R. Hospital admissions for adverse drug reactions. bpacnz internal report 2006.

Horton J, Bushwick B. Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician 1999;59:635-46.

Jaffer A, Bragg L. Practical tips for warfarin dosing and monitoring. Cleve Clin J Med 2003;70:361-71.

Janes S, Challis R, Fisher F. Safe introduction of warfarin for thrombotic prophylaxis in atrial fibrillation requiring only a weekly INR. Clin Lab Haematol 2004;26:43-7.

Lidstone V, Janes S, Stross P. INR: intervals of measurement can safely extend to 14 weeks. Clin Lab Haematol 2000;22:291-3.

Machin SJ. Medico legal problems associated with oral anticoagulant services. In oral anticoagulation management and stroke prevention: the primary care perspective. Editors: D A Fitzmaurice and E T Murray. Newmarket Medical Communications. 2002;50-57.

Medsafe, Consumer Medicine Information, 2006. http://www.medsafe.govt.nz/Consumers/cmi/m/Marevan.htm (accessed 24 August 2010).

National Guideline Clearinghouse. Anticoagulation therapy supplement, 2006. http://www.guideline.gov/summary/summary.aspx?doc_id=9273 (accessed 22 September 2006).

NZGG. The management of People with Atrial Fibrillation and Flutter, 2005. http://www.nzgg.org.nz/guidelines/0085/AF_Full_Guide_(final).pdf (accessed 22 September 2006).

Regal R, Tsui V. Optimal Understanding of Warfarin: Beyond the Nomogram. P&T 2004;29:652-9.

Schurgers L J et al. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose–response relationships in healthy subjects. Blood 2004;104:2682-9.


Page  1 | 2 | 3 | 4 | 5 | 6 | 7 Page 7